John Michael Lambert, MD | |
Navajo Route N12 And N7, Fdih Tsehootsooi Medical Center Navajo Nation, Fort Defiance, AZ 86504 | |
(928) 729-8000 | |
(928) 729-8269 |
Full Name | John Michael Lambert |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | Navajo Route N12 And N7, Fort Defiance, Arizona |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437337391 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 7754413-1205 (Utah) | Primary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
Entity Name | Mission Area Health Associates, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457427411 PECOS PAC ID: 1153302419 Enrollment ID: O20040525000425 |
News Archive
Colonoscopy is a safe and effective medical procedure that's proven to saves lives. Used for routine cancer screening, it can help identify colon tumors in their early stages. In addition, it is a key non-surgical imaging technique that allows doctors to spot ulcers, polyps or bleeding inside the large intestines of their patients safely, avoiding complications that an exploratory surgery might induce.
The relationship between gene alterations and response to anti-PD-L1 with and without anti-CTLA-4 are not well characterized.
Fibrosis is a key feature of chronic pancreatitis and pancreatic cancer. The extensive deposition of extracellular matrix proteins fosters the development of an exocrine and endocrine organ insufficiency, and accelerates progression of the tumour. Pancreatic stellate cells (PSC) are the principal effector cells in pancreatic fibrosis. They are activated by profibrogenic mediators, which include, for example, cytokines and ethanol metabolites.
CONMED Corporation (NASDAQ: CNMD) today announced financial results for the third quarter of 2009.
Nektar Therapeutics today announced positive preliminary initial results from a two-stage Phase 2 clinical study evaluating single-agent NKTR-102 in women with advanced/metastatic breast cancer patients who have received a prior taxane. The increased use of taxanes in breast cancer often renders tumors resistant to these drugs by the time the disease recurs, thereby underscoring the urgent need for new treatment options with novel mechanisms of action for metastatic disease.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
John Michael Lambert, MD 926 47th St, Apt. #1c, Brooklyn, NY 11219-2861 Ph: () - | John Michael Lambert, MD Navajo Route N12 And N7, Fdih Tsehootsooi Medical Center Navajo Nation, Fort Defiance, AZ 86504 Ph: (928) 729-8000 |
News Archive
Colonoscopy is a safe and effective medical procedure that's proven to saves lives. Used for routine cancer screening, it can help identify colon tumors in their early stages. In addition, it is a key non-surgical imaging technique that allows doctors to spot ulcers, polyps or bleeding inside the large intestines of their patients safely, avoiding complications that an exploratory surgery might induce.
The relationship between gene alterations and response to anti-PD-L1 with and without anti-CTLA-4 are not well characterized.
Fibrosis is a key feature of chronic pancreatitis and pancreatic cancer. The extensive deposition of extracellular matrix proteins fosters the development of an exocrine and endocrine organ insufficiency, and accelerates progression of the tumour. Pancreatic stellate cells (PSC) are the principal effector cells in pancreatic fibrosis. They are activated by profibrogenic mediators, which include, for example, cytokines and ethanol metabolites.
CONMED Corporation (NASDAQ: CNMD) today announced financial results for the third quarter of 2009.
Nektar Therapeutics today announced positive preliminary initial results from a two-stage Phase 2 clinical study evaluating single-agent NKTR-102 in women with advanced/metastatic breast cancer patients who have received a prior taxane. The increased use of taxanes in breast cancer often renders tumors resistant to these drugs by the time the disease recurs, thereby underscoring the urgent need for new treatment options with novel mechanisms of action for metastatic disease.
› Verified 5 days ago
Santosh Bandugula Reddy, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Corner Of Route N12 And N7, Fort Defiance, AZ 86504 Phone: 928-729-8713 | |
Junko Nakai, MD Pediatrics Medicare: Medicare Enrolled Practice Location: Corner Of Route 7 And Route 12, Fort Defiance, AZ 86504 Phone: 928-729-8000 | |
Gail Stotsky, MD Pediatrics Medicare: Medicare Enrolled Practice Location: Corner Of Route N12 And N7, Fort Defiance, AZ 86504 Phone: 928-729-8000 | |
Dr. Douglas Henry Esposito, MD, MPH, FAAP Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Corner N12 And N7, Fort Defiance, AZ 86504 Phone: 928-729-8000 Fax: 928-729-8019 | |
Paul D Smith, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Corner Of N12 And N7, Fort Defiance, AZ 86504 Phone: 928-729-8000 | |
Dr. Sarah Rose Wheatley Hartnett, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: Corner Of N12 And N7, Fort Defiance Indian Hospital, Fort Defiance, AZ 86504 Phone: 928-729-8000 |